A Study to Evaluate Unintended Prolonged Opioid Use

Overview

Información sobre este estudio

The primary purpose of this study is to identify patient characteristics that are associated with unintended prolonged opioid use (UPUO).

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Age ≥ 18 years.
  • No use of opioids for 6 months prior to the issuance of the initial opioid prescription.
  • At least 1 dose of the initial opioid prescription was taken.
  • Willingness to participate in all aspects of the study including use of the mobile health platform on their personal smartphone.
  • Patients meeting these inclusion criteria will be further categorized based on CONSORT criteria.

Criteria for the long-term CONSORT category includes:

  • Episodes of opioid prescribing lasting longer than 90 days and including 120 or more total days’ supply or 10 or more prescriptions.

Criteria for the short-term CONSORT category includes:

  • Episodes of opioid prescribing lasting 90 days or less.

Exclusion Criteria:

  • Cancer-associated pain.
  • Concurrent treatment for cancer (e.g., chemotherapy, radiation therapy).
  • Residence in an extended care facility.
  • Mental health disorders that could impede functioning in an ambulatory care setting (e.g., schizophrenia, dementia).
  • Non-English speaking individuals.
  • Although study participation will be limited to adults who own a smartphone, recent data from January 2018 demonstrate 77% of U.S. residents own a smartphone.
  • An iPad will be available for use by adults not wanting to utilize their smartphone, or for those not owning a smartphone.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

William Hooten, M.D.

Cerrado para la inscripción

Contact information:

Brenda Anderson R.N.

(507)255-7157

anderson.brenda@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20460649

Mayo Clinic Footer